RecruitingNCT07530770

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Effectiveness and Safety of Benralizumab in Allergic Bronchopulmonary Aspergillosis (ABPA): a Prospective Study of Real-world Experience

Sponsor

Qianfoshan Hospital

Enrollment

20 participants

Start Date

Sep 1, 2025

Study Type

OBSERVATIONAL

Conditions

Allergic Bronchopulmonary Aspergillosis Severe Asthma ABPA

Summary

An open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Fasenra for people with abpa, allergic bronchopulmonary aspergillosis, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFasenra

30 Mg/mL Subcutaneous Solution

Locations(2)

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China

Jinan, Shandong, China

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07530770

Related Trials

Execise Intervention in Adult Severe Asthma

NCT076550371 location

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

NCT0727672435 locations

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

NCT0736364276 locations

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

NCT0735984614 locations

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

NCT0647231037 locations